Homocysteine‐lowering interventions (high dose) vs homocysteine‐lowering interventions (low dose)
Death by any cause · people with or without existing cardiovascular disease, men and women
Homocysteine‐lowering interventions (high dose) showed no clear difference in death by any cause compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
1 finding from 1 review
- Homocysteine‐lowering interventions for preventing cardiovascular events 2017 · Cochrane Headline outcomes onlyRR 0.86 [0.66, 1.11]1 study · 3649 participantsModerate